Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors

被引：22
|
作者：
Hartl, Dana M. [1 ]
Ferte, Charles [2 ]
Loriot, Yohann [2 ]
Roca, Carlos Gomez [2 ]
Bahleda, Rastislav [2 ]
Moldovan, Cristian [2 ]
Mir, Olivier [2 ]
Soria, Jean-Charles [2 ]
机构：
[1] Inst Gustave Roussy, Dept Otolaryngol Head & Neck Surg, Paris, France
[2] Inst Gustave Roussy, Dept Med, Phase Unit SITEP 1, Paris, France
来源：
INVESTIGATIONAL NEW DRUGS | 2010年 / 28卷 / 06期
关键词：
HYPERTENSION; BEVACIZUMAB;
D O I：
10.1007/s10637-009-9314-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：884 / 886
页数：3
相关论文
共 50 条
  • [1] Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors
    Dana M. Hartl
    Charles Ferté
    Yohann Loriot
    Carlos Gomez Roca
    Rastislav Bahleda
    Cristian Moldovan
    Olivier Mir
    Jean-Charles Soria
    [J]. Investigational New Drugs, 2010, 28 : 884 - 886
  • [2] Vascular endothelial growth factor as a marker of tumor endothelium
    Brekken, RA
    Huang, XM
    King, SW
    Thorpe, PE
    [J]. CANCER RESEARCH, 1998, 58 (09) : 1952 - 1959
  • [3] Preeclampsia: The endothelium, circulating factor(s) and vascular endothelial growth factor
    Hayman, R
    Brockelsby, J
    Kenny, L
    Baker, P
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1999, 6 (01) : 3 - 10
  • [4] Preeclampsia: The Endothelium, Circulating Factor(s) and Vascular Endothelial Growth Factor
    Richard Hayman
    Jeremy Brockelsby
    Louise Kenny
    Philip Baker
    [J]. The Journal of the Society for Gynecologic Investigation: JSGI, 1999, 6 (1): : 3 - 10
  • [5] Vascular endothelium growth factor in the sera of patients with adrenal tumors
    Britvin, TA
    Kazantseva, IA
    Kalinin, AP
    Kushlinskii, NE
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 140 (02) : 228 - 230
  • [6] Vascular Endothelium Growth Factor in the Sera of Patients with Adrenal Tumors
    T. A. Britvin
    I. A. Kazantseva
    A. P. Kalinin
    N. E. Kushlinskii
    [J]. Bulletin of Experimental Biology and Medicine, 2005, 140 : 228 - 230
  • [7] Vascular permeability factor vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium
    Mukhopadhyay, D
    Nagy, JA
    Manseau, EJ
    Dvorak, HF
    [J]. CANCER RESEARCH, 1998, 58 (06) : 1278 - 1284
  • [8] A new paradigm for vascular endothelial cell growth factor receptor signaling in adult endothelium
    Ahmed, A
    Hewett, P
    [J]. CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, 2003, : 153 - 166
  • [9] Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively
    Zeng, HY
    Sanyal, S
    Mukhopadhyay, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) : 32714 - 32719
  • [10] Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
    Lin, PN
    Sankar, S
    Shan, SQ
    Dewhirst, MW
    Polverini, PJ
    Quinn, TQ
    Peters, KG
    [J]. CELL GROWTH & DIFFERENTIATION, 1998, 9 (01): : 49 - 58
12345